Literature DB >> 27104832

Integrated Genomics Reveals Convergent Transcriptomic Networks Underlying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Rebecca L Kusko1, John F Brothers1, John Tedrow2, Kusum Pandit2, Luai Huleihel2, Catalina Perdomo1, Gang Liu1, Brenda Juan-Guardela3, Daniel Kass2, Sherry Zhang1, Marc Lenburg1, Fernando Martinez4, John Quackenbush5, Frank Sciurba2, Andrew Limper6, Mark Geraci7, Ivana Yang7, David A Schwartz7, Jennifer Beane1, Avrum Spira1, Naftali Kaminski3.   

Abstract

RATIONALE: Despite shared environmental exposures, idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease are usually studied in isolation, and the presence of shared molecular mechanisms is unknown.
OBJECTIVES: We applied an integrative genomic approach to identify convergent transcriptomic pathways in emphysema and IPF.
METHODS: We defined the transcriptional repertoire of chronic obstructive pulmonary disease, IPF, or normal histology lungs using RNA-seq (n = 87).
MEASUREMENTS AND MAIN RESULTS: Genes increased in both emphysema and IPF relative to control were enriched for the p53/hypoxia pathway, a finding confirmed in an independent cohort using both gene expression arrays and the nCounter Analysis System (n = 193). Immunohistochemistry confirmed overexpression of HIF1A, MDM2, and NFKBIB members of this pathway in tissues from patients with emphysema or IPF. Using reads aligned across splice junctions, we determined that alternative splicing of p53/hypoxia pathway-associated molecules NUMB and PDGFA occurred more frequently in IPF or emphysema compared with control and validated these findings by quantitative polymerase chain reaction and the nCounter Analysis System on an independent sample set (n = 193). Finally, by integrating parallel microRNA and mRNA-Seq data on the same samples, we identified MIR96 as a key novel regulatory hub in the p53/hypoxia gene-expression network and confirmed that modulation of MIR96 in vitro recapitulates the disease-associated gene-expression network.
CONCLUSIONS: Our results suggest convergent transcriptional regulatory hubs in diseases as varied phenotypically as chronic obstructive pulmonary disease and IPF and suggest that these hubs may represent shared key responses of the lung to environmental stresses.

Entities:  

Keywords:  COPD; ILD; IPF; network; transcriptome

Mesh:

Substances:

Year:  2016        PMID: 27104832      PMCID: PMC5067817          DOI: 10.1164/rccm.201510-2026OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  51 in total

1.  Multiplatform single-sample estimates of transcriptional activation.

Authors:  Stephen R Piccolo; Michelle R Withers; Owen E Francis; Andrea H Bild; W Evan Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

2.  Digital multiplexed gene expression analysis using the NanoString nCounter system.

Authors:  Meghana M Kulkarni
Journal:  Curr Protoc Mol Biol       Date:  2011-04

Review 3.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

Authors:  Victor J Thannickal; Jeffrey C Horowitz
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Differential expressions of glycine transporter 1 and three glutamate transporter mRNA in the hippocampus of gerbils with transient forebrain ischemia.

Authors:  H Fujita; K Sato; T C Wen; Y Peng; M Sakanaka
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy.

Authors:  M Selman; T E King; A Pardo
Journal:  Ann Intern Med       Date:  2001-01-16       Impact factor: 25.391

8.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Wen Ning; Chao-Jun Li; Naftali Kaminski; Carol A Feghali-Bostwick; Sean M Alber; Yuanpu P Di; Sherrie L Otterbein; Ruiping Song; Shizu Hayashi; Zhihong Zhou; David J Pinsky; Simon C Watkins; Joseph M Pilewski; Frank C Sciurba; David G Peters; James C Hogg; Augustine M K Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

Review 9.  LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins.

Authors:  Jacqueline M Matthews; Jane E Visvader
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

10.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

View more
  56 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

2.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

3.  SH2 Domain-Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis.

Authors:  Argyrios Tzouvelekis; Guoying Yu; Christian L Lino Cardenas; Jose D Herazo-Maya; Rong Wang; Tony Woolard; Yi Zhang; Koji Sakamoto; Hojin Lee; Jae-Sung Yi; Giuseppe DeIuliis; Nikolaos Xylourgidis; Farida Ahangari; Patty J Lee; Vassilis Aidinis; Erica L Herzog; Robert Homer; Anton M Bennett; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

4.  The DNA repair transcriptome in severe COPD.

Authors:  Maor Sauler; Maxime Lamontagne; Eric Finnemore; Jose D Herazo-Maya; John Tedrow; Xuchen Zhang; Julia E Morneau; Frank Sciurba; Wim Timens; Peter D Paré; Patty J Lee; Naftali Kaminski; Yohan Bossé; Jose L Gomez
Journal:  Eur Respir J       Date:  2018-10-04       Impact factor: 16.671

5.  Localized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein.

Authors:  Ankita Burman; Jonathan A Kropski; Carla L Calvi; Ana P Serezani; Bruno D Pascoalino; Wei Han; Taylor Sherrill; Linda Gleaves; William E Lawson; Lisa R Young; Timothy S Blackwell; Harikrishna Tanjore
Journal:  JCI Insight       Date:  2018-08-23

6.  Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.

Authors:  Justin Goodwin; Hyunsung Choi; Meng-Hsiung Hsieh; Michael L Neugent; Jung-Mo Ahn; Heather N Hayenga; Pankaj K Singh; David B Shackelford; In-Kyu Lee; Vladimir Shulaev; Shanta Dhar; Norihiko Takeda; Jung-Whan Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

Review 7.  Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine.

Authors:  Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

8.  Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.

Authors:  Yan Xu; Takako Mizuno; Anusha Sridharan; Yina Du; Minzhe Guo; Jie Tang; Kathryn A Wikenheiser-Brokamp; Anne-Karina T Perl; Vincent A Funari; Jason J Gokey; Barry R Stripp; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2016-12-08

9.  A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

Authors:  Stephen Lam; Sumithra J Mandrekar; Yaron Gesthalter; Katie L Allen Ziegler; Drew K Seisler; David E Midthun; Jenny T Mao; Marie Christine Aubry; Annette McWilliams; Don D Sin; Tawimas Shaipanich; Gang Liu; Evan Johnson; Andrea Bild; Marc E Lenburg; Diana N Ionescu; John Mayo; Joanne Eunhee Yi; Henry Tazelaar; William S Harmsen; Judith Smith; Avrum E Spira; Jennifer Beane; Paul J Limburg; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2016-09-22

Review 10.  Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.

Authors:  Shuang Li; Jing Zhao; Dong Shang; Daniel J Kass; Yutong Zhao
Journal:  JCI Insight       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.